profitable 1-year investment option. VKTX price target in 14 days: Most of the world’s richest investors totally ignore company fundamentals like P/E ratios. The biotechnology company reported ($0.13) earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of ($0.14) by $0.01. As of July 15th, there was short interest totaling 9,960,000 shares, a decline of 16.4% from the June 30th total of 11,920,000 shares. The company's lead drug candidate also includes VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery. One share of VKTX stock can currently be purchased for approximately $7.30.Viking Therapeutics has a market capitalization of $531.13 million. When will VKTX stock price go down? Will VKTX stock price rise? One indicator is far more accurate -- but less than 1 in 1,000 investors have ever heard of it.Viking Therapeutics has received a consensus rating of Buy. They also gave news stories about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the next few days. View which stocks are hot on social media with MarketBeat's trending stocks report.Identify stocks that meet your criteria using seven unique stock screeners. days (7 -180) Long term predictions are excellent. Identify the most profitable chart patterns in seconds! According to our analysis, this will not happen.
News headlines about VKTX stock have been trending somewhat positive recently, InfoTrie Sentiment reports. Yes. The long-term earning potential is How will Viking Therapeutics, Inc. stock price increase? This suggests a possible upside of 102.4% from the stock's current price. VKTX Trend Top Trending Stocks. Please log in to your account or sign up in order to add this asset to your watchlist. i bet it wont even reach 15$ before november\december, this site is a joke
Is Viking Therapeutics, Inc. a profitable investment? all your stock prices are not current, could you please fix it? Carr has been one such--great results. Helps me to hang on and not sell for a little profit. See VKTX stock predictions by 3 financial experts and find out if their Viking Therapeutics stock forecast (VKTX) is more bullish in comparison to other stocks in the Healthcare sector. When will VKTX price fall? from Current Price Is Viking Therapeutics, Inc. price going up? Since then, VKTX shares have increased by 44.0% and is now trading at $7.30. Want to see which stocks are moving? Specifically, they have bought $0.00 in company stock and sold $95,550.00 in company stock.Only 3.70% of the stock of Viking Therapeutics is held by insiders.54.21% of the stock of Viking Therapeutics is held by institutions. E.K. Set a candle Be the first to comment. Sign-up to receive the latest news and ratings for VKTX and its competitors with MarketBeat's FREE daily newsletter.Viking Therapeutics' stock was trading at $5.07 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. VKTX prediction, Will VKTX price drop? Predictions, Comments & Questions 11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Viking Therapeutics in the last year. It is also developing VK0612, an orally available Phase 2b-ready drug candidate for type 2 diabetes; and VK0214, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta for X-linked adrenoleukodystrophy. Find real-time VKTX - Viking Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Not within a year. Question Box: At Walletinvestor.com we predict future values with technical analysis for wide 11 brokerages have issued twelve-month price objectives for Viking Therapeutics' stock.